{"id":18901,"date":"2026-03-18T11:34:51","date_gmt":"2026-03-18T11:34:51","guid":{"rendered":"https:\/\/www.invesdor.de\/blog\/?p=18901"},"modified":"2026-03-25T11:01:04","modified_gmt":"2026-03-25T11:01:04","slug":"medtech-and-healthcare-investments","status":"publish","type":"post","link":"https:\/\/www.invesdor.com\/blog\/medtech-and-healthcare-investments\/","title":{"rendered":"MedTech and Healthcare Investments: Opportunities, Risks, and Examples"},"content":{"rendered":"<p><strong>From diagnosis to therapy: how investments are transforming the medical and healthcare industry and strengthening portfolios<\/strong><\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 ez-toc-wrap-left counter-flat ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of contents<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class=\"ez-toc-list ez-toc-list-level-1 \"><li class=\"ez-toc-page-1\"><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.invesdor.com\/blog\/medtech-and-healthcare-investments\/#MedTech_Healthcare_Investments_at_a_Glance\">MedTech&#xA0;&amp;&#xA0;Healthcare&#xA0;Investments at a&#xA0;Glance&#xA0;&#xA0;<\/a><\/li><li class=\"ez-toc-page-1\"><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.invesdor.com\/blog\/medtech-and-healthcare-investments\/#Challenges_and_Opportunities_for_Sustainable_Investments_in_MedTech_and_Healthcare\">Challenges and&#xA0;Opportunities&#xA0;for&#xA0;Sustainable&#xA0;Investments in MedTech and&#xA0;Healthcare&#xA0;<\/a><\/li><li class=\"ez-toc-page-1\"><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.invesdor.com\/blog\/medtech-and-healthcare-investments\/#From_Research_to_Practice_Examples_of_Successful_MedTech_Investments\">From&#xA0;Research&#xA0;to&#xA0;Practice:&#xA0;Examples&#xA0;of&#xA0;Successful&#xA0;MedTech Investments<\/a><\/li><li class=\"ez-toc-page-1\"><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.invesdor.com\/blog\/medtech-and-healthcare-investments\/#Healthcare_investments_benefits_for_people_and_investors\">Healthcare&#xA0;investments: benefits&#xA0;for&#xA0;people and investors<\/a><\/li><li class=\"ez-toc-page-1\"><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.invesdor.com\/blog\/medtech-and-healthcare-investments\/#Invest_in_health_now_your_chance_to_actively_shape_the_future\">Invest&#xA0;in&#xA0;health&#xA0;now:&#xA0;your&#xA0;chance&#xA0;to&#xA0;actively&#xA0;shape&#xA0;the&#xA0;future!&#xA0;<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n\n<p><\/p>\n\n\n\n<p>How do&#xA0;investments&#xA0;in&#xA0;healthcare&#xA0;help&#xA0;close&#xA0;gaps&#xA0;in care&#xA0;while&#xA0;also&#xA0;generating&#xA0;returns?&#xA0; <strong>MedTech and&#xA0;healthcare&#xA0;investments<\/strong>&#xA0;are&#xA0;among&#xA0;the&#xA0;most&#xA0;stable&#xA0;and at&#xA0;the&#xA0;same time&#xA0;most&#xA0;innovative&#xA0;segments&#xA0;of&#xA0;the&#xA0;global&#xA0;healthcare&#xA0;market.&#xA0;&#xA0;&#xA0;<\/p>\n\n\n\n<p><strong>MedTech and healthcare investments<\/strong> refer to capital allocated to companies that develop and commercialize medical technologies, digital health solutions, or healthcare infrastructure.<\/p>\n\n\n\n<p>While&#xA0;many&#xA0;markets&#xA0;are&#xA0;subject&#xA0;to&#xA0;strong&#xA0;fluctuations,&#xA0;the&#xA0;demand&#xA0;for&#xA0;medical&#xA0;and&#xA0;healthcare&#xA0;services&#xA0;remains&#xA0;constant.&#xA0;It&#xA0;continues&#xA0;to&#xA0;grow&#xA0;with&#xA0;an&#xA0;aging&#xA0;population,&#xA0;increasing&#xA0;life&#xA0;expectancy&#xA0;&#xA0;(<em>according&#xA0;to&#xA0;the&#xA0;<a href=\"https:\/\/www.deloitte.com\/content\/dam\/assets-zone2\/be\/en\/docs\/industries\/health-care\/be-medtech-europe-report-2024-final.pdf\" target=\"_blank\" rel=\"noopener\" title=\"\">Deloitte Global Health Care Outlook 2025<\/a> the&#xA0;number&#xA0;of&#xA0;people&#xA0;over&#xA0;65 in Europe will&#xA0;increase&#xA0;by&#xA0;around&#xA0;30%&#xA0;by&#xA0;2030<\/em>)&#xA0;and&#xA0;the&#xA0;rising&#xA0;prevalence&#xA0;of&#xA0;chronic&#xA0;diseases&#xA0;such&#xA0;as&#xA0;diabetes&#xA0;and&#xA0;cardiovascular&#xA0;conditions.&#xA0;&#xA0;<\/p>\n\n\n\n<p>This&#xA0;demographic&#xA0;shift&#xA0;increases&#xA0;the&#xA0;pressure&#xA0;on&#xA0;healthcare&#xA0;systems&#xA0;and&#xA0;raises&#xA0;demand&#xA0;for&#xA0;efficient,&#xA0;technology-driven&#xA0;solutions.&#xA0;&#xA0;<\/p>\n\n\n\n<div class=\"inv-imgblock\" style=\"max-width:580px; margin-left:auto; margin-right:auto; border-radius:16px; overflow:hidden;\">\n    <img decoding=\"async\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-healtchcare-patienten-im-wartezimmer-1024x576.jpg\" alt=\"patients at waiting room\"\/>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"has-text-align-center\">Healthcare systems are reaching their limits.<br>Hospitals are struggling with overcrowding and packed waiting rooms.<br><em>Foto: envato<\/em><\/p>\n<\/div>\n<\/div>\n\n\n\n<p>At the same time, healthcare systems are reaching their limits: <strong>hospitals are struggling with overload, waiting times are increasing, and modern diagnostics are not available to everyone<\/strong>. This is where <strong>new business models and medical technologies<\/strong> come into play. They <strong>create access where gaps previously existed and improve processes<\/strong> that have so far been inefficient.<\/p>\n\n\n\n<p>For investors, this creates unique opportunities: <strong>MedTech and healthcare investments at Invesdor combine social impact with attractive return potential<\/strong>. Investors support concrete solutions with measurable impact.<\/p>\n\n\n\n<p>Through Invesdor, investors gain access to MedTech and healthcare companies that have already overcome key hurdles and are preparing for the next stage of scaling. These projects combine societal impact with financial prospects. They are also aligned with the United Nations Sustainable Development Goals (SDGs). <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"MedTech_Healthcare_Investments_at_a_Glance\"><\/span><strong><strong><strong><strong>MedTech&#xA0;&amp;&#xA0;Healthcare&#xA0;Investments at a&#xA0;Glance<\/strong><\/strong><\/strong>&#xA0;<\/strong>&#xA0;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>MedTech and healthcare investments involve companies that improve medical care while building on robust business models. <\/p>\n\n\n\n<p>In Europe, more than 90% of the MedTech sector consists of small and medium-sized enterprises (SMEs). This structure opens attractive opportunities for investors to enter early. At the same time, it requires a solid understanding of development stages, as smaller providers are more dependent on regulatory processes and scaling dynamics. <\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\" style=\"border-radius:16px; overflow:hidden;\">\n    <img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"335\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/forschung-gemini-bild.png\" alt=\"\" class=\"wp-image-19144\" style=\"width:548px; height:auto; border-radius:16px; display:block;\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/forschung-gemini-bild.png 500w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/forschung-gemini-bild-300x201.png 300w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\"\/>\n    <figcaption class=\"wp-element-caption\">Foto: Gemini<\/figcaption>\n<\/figure>\n\n\n\n<p>Germany, Switzerland, and the Netherlands are among the world&#x2019;s most innovative locations.<br>Many companies here have overcome significant challenges: they are CE-certified, have completed clinical trials, or have generated their first revenue.&#xA0;&#xA0;<\/p>\n\n\n\n<p><br><strong><strong><strong>Challenges and&#xA0;opportunities&#xA0;for&#xA0;Europe&#x2019;s&#xA0;MedTech&#xA0;market&#xA0;<\/strong><\/strong>&#xA0;<\/strong>&#xA0;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>According&#xA0;to&#xA0;the&#xA0;industry&#xA0;report&#xA0;&#xA0;&#xA0;<a href=\"https:\/\/www.medtecheurope.org\/about-the-industry\/facts-figures\" target=\"_blank\" rel=\"noopener\" title=\"\"><em>MedTech Europe Facts &amp;&#xA0;Figures<\/em><\/a>&#xA0;and <a href=\"https:\/\/www.medtecheurope.org\/wp-content\/uploads\/2024\/07\/medtech-europe--facts-figures-2024.pdf)\" target=\"_blank\" rel=\"noopener\" title=\"\"><em>MedTech Europe Facts &amp; Figures 2024<\/em><\/a><em>&#xA0;<\/em>the&#xA0;European&#xA0;medical&#xA0;technology&#xA0;market&#xA0;has&#xA0;been&#xA0;growing&#xA0;steadily&#xA0;at&#xA0;around&#xA0;5% per&#xA0;year&#xA0;for&#xA0;several&#xA0;years. <em><br>&#xA0;<br><\/em>Unlike traditional early-stage startups, many companies in this sector have already overcome key challenges: they are CE-certified, have completed clinical trials, or have generated initial revenues. &#xA0;<\/p>\n\n\n\n<p>For investors, this means they typically enter after this phase while still benefiting from significant scaling potential. <\/p>\n\n\n\n<p>Typical&#xA0;segments&#xA0;include:&#xA0;&#xA0;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>MedTech<\/strong>: devices,&#xA0;implants, and digital&#xA0;tools&#xA0;for&#xA0;diagnostics&#xA0;and&#xA0;therapy&#xA0;&#xA0;<\/li>\n\n\n\n<li><strong>Healthcare&#xA0;infrastructure<\/strong>:&#xA0;for&#xA0;example&#xA0;modern&#xA0;diagnostic&#xA0;systems&#xA0;and&#xA0;equipment&#xA0;fleets&#xA0;that&#xA0;hospitals&#xA0;can&#xA0;use&#xA0;and&#xA0;finance&#xA0;flexibly<\/li>\n\n\n\n<li><strong>Digital Health<\/strong>: &#xA0;telemedicine,&#xA0;platforms, and&#xA0;wearables&#xA0;<br><br><\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile has-background\" style=\"background-color:#e9d4e4;grid-template-columns:23% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"550\" height=\"550\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light.png\" alt=\"Graphic with hand\" class=\"wp-image-17658 size-full\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light.png 550w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light-300x300.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light-150x150.png 150w\" sizes=\"auto, (max-width: 550px) 100vw, 550px\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-dd48388e5623517385983d49cb7e3221\" style=\"color:#a2006e\">Good to know: MedTech<\/h3>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.invesdor.de\/blog\/wp-content\/uploads\/2026\/03\/grafik1_markt_en.svg\" alt=\"Infographic: Key Figures for the European MedTech Market in 2024\" class=\"wp-image-19178\" style=\"aspect-ratio:3.031259867382381;width:647px;height:auto\"\/><\/figure>\n\n\n\n<p><\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<ul class=\"wp-block-list\">\n<li>There are around 38,000 MedTech companies in Europe, about 90% of which are small and medium-sized enterprises (SMEs). <br><\/li>\n\n\n\n<li>The MedTech&#xA0;sector&#xA0;is&#xA0;one&#xA0;of&#xA0;the&#xA0;most&#xA0;innovative&#xA0;industrial&#xA0;sectors,&#xA0; accounting&#xA0;for&#xA0;<br>about&#xA0;8%&#xA0;of&#xA0;all&#xA0;industrial&#xA0;patent&#xA0;applications&#xA0;in Europe.&#xA0;<br><\/li>\n\n\n\n<li>MedTech&#xA0;contributes&#xA0;significantly&#xA0;to&#xA0;the&#xA0;economy&#xA0;in&#xA0;terms&#xA0;of&#xA0;employment,&#xA0;exports, and&#xA0;innovation. The European MedTech&#xA0;industry&#xA0;directly&#xA0;employs&#xA0;more&#xA0;than&#xA0;930,000&#xA0;people.&#xA0;<br><\/li>\n\n\n\n<li>The European MedTech&#xA0;market&#xA0;is&#xA0;estimated&#xA0;at&#xA0;around&#xA0;&#x20AC;170&#xA0;billion&#xA0;for&#xA0;2024,&#xA0;representing&#xA0;<br>about&#xA0;26.4%&#xA0;of&#xA0;the&#xA0;global&#xA0;market.&#xA0;<\/li>\n<\/ul>\n\n\n\n<p>(Sources: <a href=\"https:\/\/www.medtecheurope.org\/datahub\/employment-companies\/\" target=\"_blank\" rel=\"noopener\" title=\"\">MedTech Europe Employment &amp; Companies&#xA0;,<\/a>&#xA0;<a href=\"https:\/\/www.medtecheurope.org\/datahub\/market\/\" target=\"_blank\" rel=\"noopener\" title=\"\">MedTech Europa Market<\/a> , <a href=\"https:\/\/www.medtecheurope.org\/about-the-industry\/facts-figures\/)\" target=\"_blank\" rel=\"noopener\" title=\"\">MedTech Europe Facts &amp; Figures<\/a><a href=\"https:\/\/www.medtecheurope.org\/about-the-industry\/facts-figures\/)\" target=\"_blank\" rel=\"noreferrer noopener\">)<\/a>&#xA0;&#xA0;)<\/p>\n\n\n\n<div style=\"height:42px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><strong><strong>Health, innovation, and sustainability: Why&#xA0;Invesdor&#xA0;focuses on MedTech and Healthcare Investments<\/strong><\/strong><\/strong>&#xA0;<\/h3>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:29px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-healthcare-investments-1024x683.jpg\" alt=\"iPad with Analysis: Europe is one of the most attractive regions for medtech investments\" class=\"wp-image-19012\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-healthcare-investments-1024x683.jpg 1024w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-healthcare-investments-300x200.jpg 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-healthcare-investments-768x513.jpg 768w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/medtech-healthcare-investments.jpg 1500w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\"\/><figcaption class=\"wp-element-caption\">Foto: envato<\/figcaption><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p>According&#xA0;to&#xA0;an&#xA0;analysis&#xA0;by&#xA0;Deloitte&#xA0;(&#x201E;<a href=\"https:\/\/www.deloitte.com\/be\/en\/Industries\/health-care\/analysis\/europe-medtech-attractiveness.html\" target=\"_blank\" rel=\"noopener\" title=\"\">Europe&#x2019;s&#xA0;MedTech&#xA0;Attractiveness&#x201C;, 2025,<\/a>&#xA0;<a href=\"https:\/\/www.deloitte.com\/content\/dam\/assets-zone2\/be\/en\/docs\/industries\/health-care\/be-medtech-europe-report-2024-final.pdf\" target=\"_blank\" rel=\"noopener\" title=\"\">Europe&#x2019;s MedTech Report 2024<\/a><a href=\"https:\/\/www.deloitte.com\/content\/dam\/assets-zone2\/be\/en\/docs\/industries\/health-care\/be-medtech-europe-report-2024-final.pdf)\" target=\"_blank\" rel=\"noreferrer noopener\">)<\/a>&#xA0;Europe is one of the most attractive regions for MedTech investments. In addition to a strong regulatory framework and excellent research, well-connected innovation clusters form the backbone of the European healthcare market. &#xA0;<\/p>\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<p>These innovation clusters include in particular the Nordic countries. Finland has developed into a leading location for MedTech start-ups. You can learn what enables this success in the article <a href=\"https:\/\/www.invesdor.com\/blog\/8-reasons-for-the-success-of-finnish-medtech-companies\/\" target=\"_blank\" rel=\"noopener\" title=\"\"><strong>&#x201E;8 Reasons for the Success of Finnish MedTech Companies&#x201C;<\/strong><\/a>&#xA0;&#xA0;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Health&#xA0;as&#xA0;a Growth Engine&#xA0;of&#xA0;the&#xA0;European Economy<\/strong>&#xA0;<\/strong>&#xA0;<\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>The EFPIA&#xA0;report&#xA0;&#x201C;<a href=\"https:\/\/www.efpia.eu\/media\/xpkbiap5\/the-case-for-investing-in-a-healthier-future-for-the-european-union.pdf\" target=\"_blank\" rel=\"noopener\" title=\"\"><em>The Case&#xA0;for&#xA0;Investing&#xA0;in a&#xA0;Healthier&#xA0;Future&#xA0;for&#xA0;the&#xA0;European Union<\/em><\/a>&#x201D; also shows that every euro invested in the healthcare sector leads to higher quality of life, lower disease costs, and a more resilient economy in the long term. EFPIA concludes that health should be viewed not merely as a cost factor but as a driver of economic growth. <\/p>\n\n\n\n<p>The European MedTech sector is strongly export-oriented. According to MedTech Europe 2024, around 60% of global medical technology exports originate from Europe. For investors, this means stable international demand, currency diversification, and growth beyond national markets. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Sustainability&#xA0;and Regulation Are&#xA0;Becoming&#xA0;More&#xA0;Important<\/strong>&#xA0;<\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Invesdor views health as a central pillar of sustainable investments. Medical innovation directly improves the lives of millions of people while creating scalable business models.  Every funding request is reviewed before being listed on our platform. The connection to the UN Sustainable Development Goals (<a href=\"https:\/\/sdgs.un.org\/goals\" target=\"_blank\" rel=\"noopener\" title=\"\">SDGs<\/a>) plays an important role. Depending on the project, the following goals are particularly relevant: <\/p>\n\n\n\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:wght@700;900&amp;family=DM+Sans:wght@400;500;600&amp;display=swap\" rel=\"stylesheet\">\n\n<style>\n.sdg-list{font-family:'DM Sans',sans-serif;max-width:860px;margin:0 auto;padding:1rem 0;display:flex;flex-direction:column;gap:14px;}\n.sdg-item{display:flex;align-items:center;gap:22px;background:#ffffff;border:0.5px solid #dbdbdb;border-radius:12px;padding:22px 26px;transition:border-color 0.2s;}\n.sdg-item:hover{border-color:#b4b4b4;}\n.sdg-img{width:76px;height:76px;object-fit:cover;border-radius:10px;flex-shrink:0;}\n.sdg-content strong{display:block;font-size:17px;font-weight:600;color:#025550;margin-bottom:8px;line-height:1.3;}\n.sdg-content p{font-size:16px;color:#5b5b5a;line-height:1.78;margin:0;}\n@media(max-width:560px){.sdg-item{flex-direction:column;gap:14px;}.sdg-img{width:64px;height:64px;}}\n<\/style>\n\n<div class=\"sdg-list\">\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-03.png\" alt=\"SDG 3: Good Health and Well-being\"\/>\n    <div class=\"sdg-content\">\n      <strong>Good Health and Well-being (SDG 3)<\/strong>\n      <p>MedTech and healthcare projects improve patient care. Modern diagnostics, digital systems, and new therapies enable earlier treatment and increase the chances of recovery. Every investment in this field directly contributes to improving health and quality of life.<\/p>\n    <\/div>\n  <\/div>\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-05.png\" alt=\"SDG 5: Gender Equality\"\/>\n    <div class=\"sdg-content\">\n      <strong>Gender Equality (SDG 5)<\/strong>\n      <p>Many MedTech and healthcare projects specifically address the needs of women in healthcare. From innovations in neonatology to technologies for female-specific diseases, solutions are emerging in areas that have long been neglected. Investments in such projects strengthen gender equality in healthcare and improve care for female patients.<\/p>\n    <\/div>\n  <\/div>\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-07.png\" alt=\"SDG 7: Affordable and Clean Energy\"\/>\n    <div class=\"sdg-content\">\n      <strong>Affordable and Clean Energy (SDG 7)<\/strong>\n      <p>Energy efficiency also plays a role in healthcare. Modern devices and digital systems are increasingly designed to consume less electricity and to function reliably even in regions with unstable energy supply. For investors, this means supporting companies that use sustainable technologies while reducing costs for hospitals and patients.<\/p>\n    <\/div>\n  <\/div>\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-09.png\" alt=\"SDG 9: Industry, Innovation and Infrastructure\"\/>\n    <div class=\"sdg-content\">\n      <strong>Industry, Innovation and Infrastructure (SDG 9)<\/strong>\n      <p>Healthcare investments promote modern technologies and the expansion of medical infrastructure. This includes robotic support systems, digital platforms, and flexible diagnostic solutions. Investors support companies that transform research innovations into market-ready products.<\/p>\n    <\/div>\n  <\/div>\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-10.png\" alt=\"SDG 10: Reduced Inequalities\"\/>\n    <div class=\"sdg-content\">\n      <strong>Reduced Inequalities (SDG 10)<\/strong>\n      <p>Many healthcare projects make high-quality care accessible to more people. Pay-per-use models or mobile devices help hospitals in regions with weaker infrastructure. Investments therefore contribute to greater equality in healthcare systems.<\/p>\n    <\/div>\n  <\/div>\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-12.png\" alt=\"SDG 12: Responsible Consumption and Production\"\/>\n    <div class=\"sdg-content\">\n      <strong>Responsible Consumption and Production (SDG 12)<\/strong>\n      <p>More and more companies are developing MedTech solutions that are resource-efficient and durable. They rely on reusable components and efficient production processes. Investors thus promote both medical impact and responsible resource management.<\/p>\n    <\/div>\n  <\/div>\n  <div class=\"sdg-item\">\n    <img decoding=\"async\" class=\"sdg-img\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/E-WEB-Goal-17.png\" alt=\"SDG 17: Partnerships for the Goals\"\/>\n    <div class=\"sdg-content\">\n      <strong>Partnerships for the Goals (SDG 17)<\/strong>\n      <p>Progress in healthcare emerges through collaboration. Start-ups, hospitals, universities, and investors work together to bring innovations to market faster. Every investment strengthens this network and amplifies the impact of medical advancements.<\/p>\n    <\/div>\n  <\/div>\n<\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>We&#xA0;select&#xA0;projects&#xA0;that&#xA0;meet&#xA0;SDG&#xA0;standards. This&#xA0;ensures&#xA0;that&#xA0;investors&#xA0;support robust&#xA0;business&#xA0;models&#xA0;while&#xA0;contributing&#xA0;to&#xA0;solutions&#xA0;that&#xA0;promote&#xA0;ecological, social, and&#xA0;economic&#xA0;sustainability&#xA0;in&#xA0;healthcare.&#xA0;<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Challenges_and_Opportunities_for_Sustainable_Investments_in_MedTech_and_Healthcare\"><\/span><strong><strong>Challenges and&#xA0;Opportunities&#xA0;for&#xA0;Sustainable&#xA0;Investments in MedTech and&#xA0;Healthcare<\/strong><\/strong>&#xA0;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><\/p>\n\n\n\n<p>The healthcare and MedTech sector is considered one of the most exciting areas for investors&#x2014;stable, innovative, and with clear societal relevance. At the same time, it is complex: regulations, clinical trials, and technological developments determine the pace and involve elevated risks. Investors should understand these mechanisms and be prepared for longer timelines. With foresight, real and sustainable value can emerge. <\/p>\n\n\n\n<style>\n.ch-wrap{font-family:'DM Sans',sans-serif;padding:2rem 0 1rem;max-width:860px;margin:0 auto;}\n.ch-intro{font-size:15px;color:#5b5b5a;line-height:1.75;max-width:680px;margin-bottom:1.5rem;}\n.ch-legend{display:flex;gap:16px;margin-bottom:1.75rem;flex-wrap:wrap;}\n.ch-legend-item{display:flex;align-items:center;gap:7px;font-size:13px;color:#5b5b5a;}\n.ch-dot{width:10px;height:10px;border-radius:50%;flex-shrink:0;}\n.ch-dot-chance{background:#025550;}\n.ch-dot-risk{background:#a2006e;}\n.ch-grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(260px,1fr));gap:14px;margin-bottom:1.5rem;}\n.ch-card{background:#ffffff;border:0.5px solid #dbdbdb;border-radius:12px;padding:22px 20px;position:relative;overflow:hidden;transition:border-color 0.2s;}\n.ch-card:hover{border-color:#b4b4b4;}\n.ch-bar{position:absolute;top:0;left:0;right:0;height:3px;}\n.ch-bar-chance{background:#025550;}\n.ch-bar-risk{background:#a2006e;}\n.ch-num{font-family:'Playfair Display',serif;font-size:2.4rem;font-weight:900;line-height:1;margin-bottom:10px;}\n.ch-num-chance{color:#cdd4d4;}\n.ch-num-risk{color:#e9d4e4;}\n.ch-card h3{font-size:14px;font-weight:600;margin:0 0 8px;line-height:1.35;}\n.ch-card-chance h3{color:#025550;}\n.ch-card-risk h3{color:#a2006e;}\n.ch-badge{display:inline-block;font-size:11px;font-weight:600;letter-spacing:0.04em;padding:2px 10px;border-radius:100px;margin-bottom:10px;}\n.ch-badge-chance{background:#edf4f4;color:#025550;}\n.ch-badge-risk{background:#fbf5f9;color:#a2006e;}\n.ch-card p{font-size:13px;color:#5b5b5a;line-height:1.7;margin:0;}\n.ch-footer{background:#f3ece9;border-left:3px solid #025550;border-radius:0 8px 8px 0;padding:18px 22px;font-size:14px;color:#5b5b5a;line-height:1.75;}\n.ch-footer strong{color:#1c1c1c;}\n@media(max-width:600px){.ch-grid{grid-template-columns:1fr;}}\n<\/style>\n\n<div class=\"ch-wrap\">\n\n  <div class=\"ch-legend\">\n    <div class=\"ch-legend-item\"><div class=\"ch-dot ch-dot-chance\"><\/div> Opportunity<\/div>\n    <div class=\"ch-legend-item\"><div class=\"ch-dot ch-dot-risk\"><\/div> Risk \/ Note<\/div>\n  <\/div>\n\n  <div class=\"ch-grid\">\n\n    <div class=\"ch-card\">\n      <div class=\"ch-bar ch-bar-risk\"><\/div>\n      <div class=\"ch-num ch-num-risk\">01<\/div>\n      <div class=\"ch-badge ch-badge-risk\">Risk<\/div>\n      <h3 class=\"ch-card-risk\">Medium- to Long-Term Time Horizon<\/h3>\n      <p>New medical technologies take time. From the initial idea through preclinical testing to regulatory approval, several years often pass. During this period, revenues may still be limited while development costs must be financed. Once a product reaches the market, its value can increase significantly, particularly after successful CE certification or completed clinical trials.<\/p>\n    <\/div>\n\n    <div class=\"ch-card\">\n      <div class=\"ch-bar ch-bar-chance\"><\/div>\n      <div class=\"ch-num ch-num-chance\">02<\/div>\n      <div class=\"ch-badge ch-badge-chance\">Opportunity<\/div>\n      <h3 class=\"ch-card-chance\">More Favorable Risk&#x2013;Return Profile<\/h3>\n      <p>Many companies on Invesdor are no longer in the highest-risk start-up phase. They have already achieved important milestones such as CE certification, clinical trials, or initial revenues. This allows investors to benefit from a more favorable risk&#x2013;return profile while gaining access to companies with strong scaling potential.<\/p>\n    <\/div>\n\n    <div class=\"ch-card\">\n      <div class=\"ch-bar ch-bar-risk\"><\/div>\n      <div class=\"ch-num ch-num-risk\">03<\/div>\n      <div class=\"ch-badge ch-badge-risk\">Risk<\/div>\n      <h3 class=\"ch-card-risk\">Plan for Multiple Financing Rounds<\/h3>\n      <p>Developing medical technology products often requires several financing rounds. Each round brings new opportunities but can also lead to dilution. Valuations often increase as development progresses, even before significant revenue is generated, creating value through technological advancement.<\/p>\n    <\/div>\n\n    <div class=\"ch-card\">\n      <div class=\"ch-bar ch-bar-chance\"><\/div>\n      <div class=\"ch-num ch-num-chance\">04<\/div>\n      <div class=\"ch-badge ch-badge-chance\">Opportunity<\/div>\n      <h3 class=\"ch-card-chance\">CE Certification as a Key Milestone<\/h3>\n      <p>In healthcare, CE certification is a major milestone. It opens access to the European market and signals that a product meets all safety and quality standards. For investors, this often marks the transition from development to scaling and therefore significant growth potential.<\/p>\n    <\/div>\n\n    <div class=\"ch-card\">\n      <div class=\"ch-bar ch-bar-chance\"><\/div>\n      <div class=\"ch-num ch-num-chance\">05<\/div>\n      <div class=\"ch-badge ch-badge-chance\">Opportunity<\/div>\n      <h3 class=\"ch-card-chance\">Exit Opportunities Through Acquisitions<\/h3>\n      <p>Successful MedTech companies are often acquired by larger corporations or enter partnerships with global players. These exits can generate substantial value increases for investors. Innovative niche solutions are frequently integrated into international healthcare companies within a relatively short period of time.<\/p>\n    <\/div>\n\n    <div class=\"ch-card\">\n      <div class=\"ch-bar ch-bar-chance\"><\/div>\n      <div class=\"ch-num ch-num-chance\">06<\/div>\n      <div class=\"ch-badge ch-badge-chance\">Opportunity<\/div>\n      <h3 class=\"ch-card-chance\">Co-Investors as a Signal of Confidence<\/h3>\n      <p>When institutional or experienced industry investors participate, they contribute not only capital but also expertise and networks that help companies navigate regulatory hurdles and accelerate growth. For private investors, this provides additional stability and confirmation that the business model is viable.<\/p>\n    <\/div>\n\n  <\/div><br>\n\n  <div class=\"ch-footer\">\n    <strong>MedTech and healthcare investments are not suited for short-term speculation,<\/strong> but for strategically minded investors who want to combine returns with purpose. Those willing to engage with the development of innovations and pursue a long-term goal can benefit both financially and societally.\n  <\/div>\n<\/div>\n\n\n\n<div style=\"height:29px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:45px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"From_Research_to_Practice_Examples_of_Successful_MedTech_Investments\"><\/span><strong><strong>From&#xA0;Research&#xA0;to&#xA0;Practice:&#xA0;Examples&#xA0;of&#xA0;Successful&#xA0;MedTech Investments<\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The following examples illustrate different areas of modern MedTech investments. They range from highly specialized diagnostics to digital platform solutions and practical medical aids for everyday life. Each project addresses a clear clinical need, relies on scalable technology, and combines measurable healthcare impact with a sustainable business model. This highlights what matters to investors: evidence-based solutions, transparent milestones, and a clear path to scaling. <\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Megin: <strong>precise&#xA0;brain&#xA0;diagnostics&#xA0;with&#xA0;MEG technology,&#xA0;used&#xA0;worldwide<\/strong><\/strong> <\/h3>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\"><div class=\"wp-block-image\">\n<figure class=\"alignleft size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/megin-ml-1024x576.png\" alt=\"Megin MEG-System TRIUX Neo f&#xFC;r Hirndiagnostik in der Klinik\" class=\"wp-image-19085\" style=\"aspect-ratio:1.4949112952561037\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/megin-ml-1024x576.png 1024w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/megin-ml-300x169.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/megin-ml-768x432.png 768w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/megin-ml-1536x864.png 1536w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/megin-ml.png 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<div style=\"height:24px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><a href=\"https:\/\/www.invesdor.com\/rounds\/c244d249-74e3-4d89-a147-3b479f5cc49d#\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Megin<\/a> is a Finnish MedTech company specializing in magnetoencephalography (MEG). This technology measures the magnetic fields generated by electrical signals in the brain, enabling physicians to analyze brain activity in real time.<\/p>\n<\/div>\n<\/div>\n\n\n\n<div style=\"height:13px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>This is particularly helpful for complex neurological conditions such as epilepsy or brain tumors. More precise diagnostics simplify the planning of surgeries and therapies. <\/p>\n\n\n\n<p>Megin was founded in 1989 and is headquartered in Helsinki. The company is one of the global leaders in MEG technology. More than 120 systems are already installed in hospitals and research institutions. According to the company, it holds over 80% market share in new MEG system installations.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Clinical&#xA0;need&#xA0;and&#xA0;solution:&#xA0;precise&#xA0;mapping&#xA0;of&#xA0;brain&#xA0;function<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Neurological&#xA0;diseases&#xA0;often&#xA0;present&#xA0;medicine&#xA0;with&#xA0;a&#xA0;precision&#xA0;challenge.&#xA0;For&#xA0;many&#xA0;procedures,&#xA0;it&#xA0;is&#xA0;crucial&#xA0;to&#xA0;accurately&#xA0;locate&#xA0;specific&#xA0;brain&#xA0;regions.&#xA0;<\/p>\n\n\n\n<p>Megin&#x2019;s&#xA0;TRIUX&#xA0;Neo&#xA0;system&#xA0;measures&#xA0;the&#xA0;weak&#xA0;magnetic&#xA0;fields&#xA0;produced&#xA0;by&#xA0;neuronal&#xA0;activity. This&#xA0;allows&#xA0;functional&#xA0;brain&#xA0;areas&#xA0;to&#xA0;be&#xA0;visualized&#xA0;with&#xA0;extremely&#xA0;high temporal and&#xA0;spatial&#xA0;resolution. The&#xA0;method&#xA0;is&#xA0;non-invasive and&#xA0;does&#xA0;not&#xA0;involve&#xA0;radiation&#xA0;exposure.&#xA0;<\/p>\n\n\n\n<p>This&#xA0;information&#xA0;helps&#xA0;physicians&#xA0;plan&#xA0;procedures&#xA0;more&#xA0;precisely&#xA0;and&#xA0;reduce&#xA0;risks.&#xA0;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Technology and&#xA0;status:&#xA0;established&#xA0;solution&#xA0;in a&#xA0;specialized&#xA0;market<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Megin is considered an established provider in a technically demanding segment of medical technology. Its systems are used worldwide in hospitals and research institutions. Patents, specialized technical expertise, and regulatory requirements create barriers to entry for new competitors. At the same time, demand for precise brain diagnostics is increasing as neurological diseases rise globally.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Impact:&#xA0;better&#xA0;diagnostics&#xA0;and&#xA0;more&#xA0;targeted&#xA0;treatments<\/strong><\/strong> <\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>When physicians can localize brain functions more precisely, surgeries and therapies can be planned more effectively. This helps reduce risks and improve treatment outcomes. This aligns with the sustainability goal SDG 3 &#x201C;Good Health and Well-being.&#x201D; Advances in neurological diagnostics contribute to improving patient care in the long term. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Investor&#xA0;benefit:&#xA0;fixed-interest&#xA0;bond&#xA0;with&#xA0;clear&#xA0;terms<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>The&#xA0;company&#xA0;was&#xA0;financed&#xA0;through&#xA0;a&#xA0;bond. The&#xA0;terms&#xA0;are&#xA0;clearly&#xA0;structured:&#xA0;&#xA0;<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.invesdor.de\/blog\/wp-content\/uploads\/2026\/03\/megin-grafik_english.svg\" alt=\"Infografik: Anleihekonditionen Megin MedTech-Investment\" class=\"wp-image-19238\" style=\"aspect-ratio:1.8890279516061743;width:630px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<p>The financing round reached more than &#x20AC;3.5 million and was supported by more than 1,200 investors. <\/p>\n\n\n\n<p>Megin generates revenue through the sale of MEG systems and service contracts for maintenance and operation. These service contracts provide recurring revenue. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Risks&#xA0;and&#xA0;management:&#xA0;investment&#xA0;cycles&#xA0;and&#xA0;regulatory&#xA0;requirements<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>The market for highly specialized medical technology is characterized by investment cycles. Hospitals often make large equipment decisions on a long-term and project-based basis. In addition, the installation of an MEG system requires specialized infrastructure such as magnetically shielded rooms. Regulatory requirements and production processes also shape the industry. Megin addresses these challenges through decades of industry experience, an installed system base, and international customer relationships. <\/p>\n\n\n\n<p>Megin illustrates how specialized medical technology can combine investment opportunities with medical progress. Hospitals gain access to precise brain diagnostics while investors participate through a structured bond in the further development of this technology.<\/p>\n\n\n\n<p>&#xA0;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:56px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Pirche:&#xA0;AI-powered&#xA0;platform&#xA0;making organ transplantation more&#xA0;predictable<\/strong><\/h3>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<div style=\"height:38px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"620\" height=\"434\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche.png\" alt=\"Pirche AI Platform for Transplant Medicine\" class=\"wp-image-18862\" style=\"aspect-ratio:1.4949112952561037\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche.png 620w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche-300x210.png 300w\" sizes=\"auto, (max-width: 620px) 100vw, 620px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<div style=\"height:24px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong><a href=\"https:\/\/www.inveahttps:\/\/www.invesdor.com\/rounds\/3a9e051e-ce78-42ef-a34a-e876bbfb68cb?_gl=1*wqgniy*_gcl_au*MjAyNzg2NTAxNC4xNzY4MjE5MjcyLjIwNzg1OTY1NzguMTc3MjYyNTI4MS4xNzcyNjI1Mjgx#\/sdor.de\/projekte\/3a9e051e-ce78-42ef-a34a-e876bbfb68cb#\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Pirche<\/a><\/strong>&#xA0;develops a digital diagnostics platform for transplant centers and clinical laboratories. After an organ transplant, immunological compatibility often determines how long a transplanted organ remains functional. Pirche focuses precisely on this point. The platform combines genetic typing with AI-driven modeling and supports physicians in identifying risks earlier and managing therapies more precisely. \n\n&#xA0;<\/p>\n<\/div>\n<\/div>\n\n\n\n<p>The need is significant. Many transplanted organs lose function within five to ten years. For patients, this means additional procedures, intensive treatments, and increased health burdens. Any improvement in donor organ matching and post-transplant care can therefore make a meaningful difference. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Clinical&#xA0;need&#xA0;and&#xA0;solution:&#xA0;better&#xA0;matching&#xA0;and&#xA0;more&#xA0;targeted&#xA0;follow-up&#xA0;care&#xA0;<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>In transplant medicine, laboratories and medical teams already compare key parameters such as blood type and HLA markers. However, this information is not always sufficient to reliably estimate long-term risks. Pirche expands this analysis with additional immunological models. <\/p>\n\n\n\n<p><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1000\" height=\"527\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche-2.png\" alt=\"Immune Risk Profile Analysis on the Pirche Platform\" class=\"wp-image-19090\" style=\"aspect-ratio:1.8975680350146482;width:626px;height:auto\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche-2.png 1000w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche-2-300x158.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/pirche-2-768x405.png 768w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\"\/><\/figure>\n<\/div>\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:15px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>The platform creates individualized immune risk profiles and supports clinical decision-making with advanced analyses. It uses data that is already available in many clinical laboratories, allowing the technology to integrate into existing workflows without requiring additional data collection. <\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Technology and&#xA0;status: patent-protected,&#xA0;scientifically&#xA0;documented,&#xA0;integrated&#xA0;into&#xA0;hospital&#xA0;IT<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Pirche combines genetic typing with AI-based analysis to visualize complex interactions between donor and recipient. The underlying algorithms are protected by patents and have been examined in numerous scientific publications. <\/p>\n\n\n\n<p>The platform has already been used in a large number of patient cases and further developed in collaboration with international hospitals and research institutions. Partnerships with laboratory providers such as Thermo Fisher Scientific and Werfen-Immucor facilitate integration into existing hospital IT systems. &#xA0;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Impact:&#xA0;better&#xA0;treatment&#xA0;outcomes&#xA0;and&#xA0;more&#xA0;efficient&#xA0;resource&#xA0;use<\/strong><\/h4>\n\n\n\n<p>When risks are identified earlier, follow-up care and immunosuppression can be adjusted more precisely. This can help reduce complications and extend the functional lifespan of transplanted organs. Such progress contributes to SDG 3 &#x201C;Good Health and Well-being.&#x201D; <\/p>\n\n\n\n<p>Responsible use of medical resources also plays a role. Donor organs are extremely scarce. More precise matching can help extend their usability and avoid repeated procedures. <\/p>\n\n\n\n<p>In addition, the analysis considers specific risk groups in transplant medicine, such as highly sensitized patients. This can help reduce inequalities in healthcare access.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Investor&#xA0;benefit:&#xA0;participation&#xA0;in a&#xA0;scalable&#xA0;B2B SaaS&#xA0;platform<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>The financing took place through an equity investment (security). The price per share was &#x20AC;15.85, with a minimum investment of 20 shares. Between 1.07% and 5.15% equity was offered at a pre-money valuation of approximately &#x20AC;36.86 million. In total, 578 investors participated. <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.invesdor.de\/blog\/wp-content\/uploads\/2026\/03\/pirche_investoradvantage_en.svg\" alt=\"Infographic: Pirche&#x2019;s Investor Advantage &#x2013; B2B SaaS Healthcare\" class=\"wp-image-19264\" style=\"aspect-ratio:2.600216684723727;width:607px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<p>The business model is based on software-as-a-service contracts with transplant centers and clinical laboratories. Hospitals access the platform through subscriptions, while partnerships with laboratory service providers enable further integration opportunities. Such models can generate recurring revenue when software becomes permanently integrated into clinical workflows. <\/p>\n\n\n\n<p>The investor base includes experienced entrepreneurs and investors from the healthcare industry, including individuals with backgrounds in biotechnology. These investors contribute not only capital but also industry expertise and networks. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Risks&#xA0;and&#xA0;management:&#xA0;clinical&#xA0;adoption,&#xA0;regulation, and&#xA0;market&#xA0;dynamics<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Digital diagnostics in clinical practice requires trust, strong evidence, and seamless integration. Pirche addresses these requirements through scientific documentation, a large number of evaluated cases, and IT partnerships. Nevertheless, the speed at which hospitals adopt new decision-support software into processes and budgets remains a key factor. <\/p>\n\n\n\n<p>Regulatory requirements for healthcare software, particularly AI-based systems, also shape development. Pirche focuses strongly on the US transplant market, which offers opportunities but also introduces certain dependencies. <\/p>\n\n\n\n<p>Pirche demonstrates how digital diagnostics can create value in a highly critical medical field. Hospitals gain a platform for improved risk management, patients may benefit from more stable outcomes, and investors participate in a patent-protected B2B SaaS model with documented usage and a clear commercialization strategy.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:39px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>STIL: <strong>Steady Hands&#xA0;for&#xA0;an Independent Life<\/strong><\/strong><\/h3>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div style=\"height:38px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1190\" height=\"606\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/STIL.png\" alt=\"STIL orthosis reduces tremors in Parkinson's disease and essential tremor\" class=\"wp-image-18872\" style=\"aspect-ratio:1.59;width:388px;height:auto\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/STIL.png 1190w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/STIL-300x153.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/STIL-1024x521.png 1024w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/STIL-768x391.png 768w\" sizes=\"auto, (max-width: 1190px) 100vw, 1190px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<div style=\"height:57px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong><a href=\"https:\/\/www.invesdor.com\/rounds\/52029e75-74bc-4ab2-8cba-02963ed3d4de#\/\" target=\"_blank\" rel=\"noopener\" title=\"\">STIL<\/a> <\/strong>&#xA0;develops an orthosis that stabilizes the hands. A cup of coffee remains steady. A pen produces a readable signature again. A shirt button can be fastened without help. This is exactly where the STIL orthosis helps. It sits lightly on the forearm, specifically dampens tremors, and works immediately. Clinical data shows tremor reduction of more than 80 percent. Users regain control, can perform everyday tasks independently, and feel more confident.<\/p>\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<p>Since 2023, STIL has been in use&#x2014;first in the Netherlands and now also in Germany, Belgium, and Italy. Medical supply stores and orthopedic partners fit the orthosis and support users, bringing the solution directly into daily life. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Clinical&#xA0;need&#xA0;and&#xA0;solution:&#xA0;effective,&#xA0;practical,&#xA0;immediately&#xA0;available<\/strong><\/strong><\/h4>\n\n\n\n<p>Tremors significantly limit everyday life. Eating, writing, or dressing becomes difficult. Shame often leads to social withdrawal.<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n <div class=\"brlbs-cmpnt-container brlbs-cmpnt-content-blocker brlbs-cmpnt-with-individual-styles\" data-borlabs-cookie-content-blocker-id=\"default\" data-borlabs-cookie-content=\"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\"><div class=\"brlbs-cmpnt-cb-preset-a\"> <p class=\"brlbs-cmpnt-cb-description\">You are currently viewing a placeholder content from <strong>Default<\/strong>. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.<\/p> <div class=\"brlbs-cmpnt-cb-buttons\"> <a class=\"brlbs-cmpnt-cb-btn\" href=\"#\" data-borlabs-cookie-unblock role=\"button\">Unblock content<\/a> <a class=\"brlbs-cmpnt-cb-btn\" href=\"#\" data-borlabs-cookie-accept-service role=\"button\" style=\"display: none\">Accept required service and unblock content<\/a> <\/div> <a class=\"brlbs-cmpnt-cb-provider-toggle\" href=\"#\" data-borlabs-cookie-show-provider-information role=\"button\">More Information<\/a> <\/div><\/div>\n<\/div><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><\/div>\n<\/div>\n\n\n\n<p><\/p>\n\n\n\n<p>  The STIL orthosis mechanically stabilizes the arm. It dampens uncontrolled movements without restricting natural motion. The effect is immediate. No electricity is required. The orthosis is easy to put on and adjust, even at older ages. Medical supply providers and orthopedic specialists support patients locally. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Technology and&#xA0;status:&#xA0;certification&#xA0;and&#xA0;clinical&#xA0;data<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>The STIL orthosis is CE-certified and FDA-registered. STIL operates under ISO 13485. A clinical study demonstrates its effectiveness for essential tremor, while additional studies are expanding its application to Parkinson&#x2019;s disease and other movement disorders. The modular design adapts to different sizes and needs. Distribution partners in the Netherlands, Germany, Belgium, and Italy expand market reach. A new AI-based app supports screening and simplifies initial assessments for patients and distributors. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Impact:&#xA0;more&#xA0;independence,&#xA0;lower&#xA0;costs,&#xA0;stronger&#xA0;participation<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Reduced tremors allow people to eat, write, and work independently again. This strengthens dignity and participation. Hospitals and insurers benefit from a non-invasive alternative to surgery or long-term medication. The orthosis helps reduce follow-up costs and relieve healthcare systems. It contributes to SDG 3 and, through durable and repairable product design, also supports SDG 9 (Industry, Innovation and Infrastructure), SDG 10 (Reduced Inequalities), and SDG 12 (Responsible Consumption and Production). <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Investor&#xA0;benefit:&#xA0;validated&#xA0;technology, rapid&#xA0;distribution, large&#xA0;market<\/strong><\/strong><\/h4>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"582\" src=\"https:\/\/www.invesdor.de\/blog\/wp-content\/uploads\/2026\/03\/stil-screenshot-projectsite-1024x582.png\" alt=\"STIL MedTech &#x2013; Financials on invesdor.com\" class=\"wp-image-19293\" style=\"aspect-ratio:1.7266187050359711;width:738px;height:auto\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/stil-screenshot-projectsite-1024x582.png 1024w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/stil-screenshot-projectsite-300x170.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/stil-screenshot-projectsite-768x436.png 768w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/stil-screenshot-projectsite-1536x872.png 1536w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/stil-screenshot-projectsite-2048x1163.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\"\/><\/figure>\n\n\n\n<p>STIL combines medical benefit with a clear go-to-market strategy. Distribution runs through an established network of medical supply stores and orthopedic partners, including <strong>Ottobock (Italy), STOLLE (Germany), and VIGO (Belgium)<\/strong>. The addressable market in the EU and the US is worth billions. Renowned investors such as Health Innovations, Rabobank, the EIC Accelerator, and the Brain Foundation Netherlands support growth. The latest valuation was &#x20AC;10 million pre-money. The round offered strengthened shareholder rights for new investors and followed a clear exit logic.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong><strong>Risks&#xA0;and&#xA0;management:&#xA0;reimbursement,&#xA0;adoption,&#xA0;scaling,&#xA0;regulation<\/strong><\/strong><\/h4>\n\n\n\n<p><\/p>\n\n\n\n<p>Reimbursement pathways vary by market. STIL works with pilot centers, key opinion leaders, and partners to secure coverage. Adoption in daily practice is supported by training, simple fitting processes, and distributor support. Scaling and supply chains are planned step by step with clear quality processes. CE certification, FDA registration, and ongoing studies reduce regulatory uncertainty. The AI screening app improves matching and increases success rates in patient care. <\/p>\n\n\n\n<p>STIL brings a clinically validated, non-invasive solution into standard care. Patients gain independence in daily life. Healthcare providers operate more efficiently. Investors gain access to a scalable MedTech company with a clear distribution strategy, growing partnerships, and strong validation.<\/p>\n\n\n\n<p>&#xA0;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Healthcare_investments_benefits_for_people_and_investors\"><\/span><strong><strong>Healthcare&#xA0;investments: benefits&#xA0;for&#xA0;people and investors<\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><\/p>\n\n\n\n<p>Investments in MedTech and healthcare combine economic stability with social impact. They allow investors to actively contribute to improving medical care while achieving attractive long-term returns. <\/p>\n\n\n\n<p>MedTech and healthcare projects are a valuable addition to a diversified portfolio. They respond to global megatrends such as demographic change, technological innovation, and the growing demand for efficient healthcare.<\/p>\n\n\n\n<p>For Invesdor, it makes sense to focus on companies that: <\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"40\" height=\"36\" class=\"wp-image-18354\" style=\"width: 40px;\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png\" alt=\"Check\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png 728w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check-300x272.png 300w\" sizes=\"auto, (max-width: 40px) 100vw, 40px\"\/> <strong>develop new medical technologies that improve diagnostics, therapy, or care, <br><img loading=\"lazy\" decoding=\"async\" width=\"40\" height=\"36\" class=\"wp-image-18354\" style=\"width: 40px;\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png\" alt=\"Check\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png 728w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check-300x272.png 300w\" sizes=\"auto, (max-width: 40px) 100vw, 40px\"\/> <strong>optimize&#xA0;existing&#xA0;systems&#xA0;by&#xA0;digitizing&#xA0;processes&#xA0;or&#xA0;making&#xA0;devices&#xA0;more&#xA0;sustainable,&#xA0;<\/strong><br><img loading=\"lazy\" decoding=\"async\" width=\"40\" height=\"36\" class=\"wp-image-18354\" style=\"width: 40px;\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png\" alt=\"Check\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png 728w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check-300x272.png 300w\" sizes=\"auto, (max-width: 40px) 100vw, 40px\"\/> <strong>expand&#xA0;medical&#xA0;infrastructure,&#xA0;for&#xA0;example&#xA0;through&#xA0;pay-per-use&#xA0;models&#xA0;or&#xA0;mobile&#xA0;solutions,&#xA0;<\/strong>&#xA0;<br><img loading=\"lazy\" decoding=\"async\" width=\"40\" height=\"36\" class=\"wp-image-18354\" style=\"width: 40px;\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png\" alt=\"Check\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check.png 728w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2024\/10\/check-300x272.png 300w\" sizes=\"auto, (max-width: 40px) 100vw, 40px\"\/> <strong>scale&#xA0;internationally&#xA0;to&#xA0;bring&#xA0;innovations&#xA0;to&#xA0;new&#xA0;markets&#xA0;more&#xA0;quickly.&#xA0;<\/strong>&#xA0;<\/strong><\/p>\n\n\n\n<p>Such projects meet clear sustainability and quality standards and offer strong value creation potential. <\/p>\n\n\n\n<p>The healthcare sector is considered particularly <strong>resilient<\/strong>: people require medical services regardless of economic cycles. Healthcare investments therefore offer long-term stability. Companies with CE certifications and validated clinical data increasingly meet strict regulatory requirements, which further strengthens their market position.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/icon_chancen.svg\" alt=\"Icon Opportunities in MedTech Investments\" class=\"wp-image-19068\" style=\"aspect-ratio:1;object-fit:contain;width:130px\"\/><figcaption class=\"wp-element-caption\"><strong>   <\/strong> <\/figcaption><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p>MedTech and healthcare offer growth potential through scaling, market expansion into new regions, and possible exits to larger corporations. Investors benefit from the combination of measurable impact, innovation dynamics, and predictable return models&#x2014;whether through bonds with fixed interest or equity investments with upside potential. <\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<div style=\"height:18px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/icon_risiken.svg\" alt=\"Icon: Risks Associated with Healthcare Investments\" class=\"wp-image-19073\" style=\"aspect-ratio:1;object-fit:contain;width:130px\"\/><figcaption class=\"wp-element-caption\"><strong>   <\/strong> <\/figcaption><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p>As with any asset class, risks exist. In the MedTech sector, these include potential delays in studies, regulatory changes, or longer approval processes. Liquidity challenges or dilution in follow-up financing rounds can also influence return profiles. Equity investments also carry the risk of partial or total loss. <\/p>\n<\/div>\n<\/div>\n\n\n\n<p>A <strong>structured due diligence process<\/strong> such as the one applied by Invesdor helps reduce these risks. <\/p>\n\n\n\n<p>Projects are evaluated based on financial metrics, clinical evidence, ESG criteria, and sustainability standards. This provides investors with access to vetted, viable, and impact-oriented companies.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>An investment in the healthcare sector allows investors to influence the future of medical care. Those who invest in MedTech and healthcare contribute to accelerating innovation, improving patient access to treatment, and strengthening healthcare systems worldwide&#x2014;while combining this social contribution with a clear economic perspective. <\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile has-background\" style=\"background-color:#e9d4e4;grid-template-columns:21% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"550\" height=\"550\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light.png\" alt=\"Graphic with hand\" class=\"wp-image-17658 size-full\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light.png 550w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light-300x300.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2025\/06\/light-150x150.png 150w\" sizes=\"auto, (max-width: 550px) 100vw, 550px\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<h3 class=\"wp-block-heading has-text-color has-link-color wp-elements-acd2adfdbb0a47b46ebe3c1be69c5509\" style=\"color:#a2006e\"><br>God to know:&#xA0; <strong>How&#xA0;Invesdor&#xA0;selects Healthcare and MedTech projects<\/strong>&#xA0;<\/h3>\n\n\n\n<p>Invesdor reviews every project through multiple stages to ensure quality, transparency, and sustainability: <\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/www.invesdor.de\/blog\/wp-content\/uploads\/2026\/03\/invesdor_process_en.svg\" alt=\"Infographic: Invesdor's Evaluation Process for MedTech Projects\" class=\"wp-image-19319\" style=\"aspect-ratio:3.7780401416765055;width:557px;height:auto\"\/><\/figure>\n<\/div>\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<p>Only about 5% of submitted projects make it onto the Invesdor platform. Further details about the evaluation process for investment opportunities can be found here: <a href=\"https:\/\/www.invesdor.com\/investment_evaluation_process#\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Investment Evaluation Process<\/a>.<br><\/p>\n<\/div>\n\n\n\n<div style=\"height:30px;width:0px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:47px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\"><span class=\"ez-toc-section\" id=\"Invest_in_health_now_your_chance_to_actively_shape_the_future\"><\/span><strong>Invest&#xA0;in&#xA0;health&#xA0;now:&#xA0;your&#xA0;chance&#xA0;to&#xA0;actively&#xA0;shape&#xA0;the&#xA0;future<\/strong>!&#xA0;<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"has-text-align-center\">Healthcare and MedTech investments combine financial stability with social impact. Investors support innovations that improve lives&#x2014;from advanced diagnostics and digital health solutions to new medical technologies. At the same time, they benefit from a growth market that is largely independent of economic cycles. <\/p>\n\n\n\n<p class=\"has-text-align-center\">Those who invest in this sector promote progress, improve access to better care, and actively shape the future of medicine. <\/p>\n\n\n\n<p class=\"has-text-align-center\"><strong>Discover current investment opportunities on Invesdor: <\/strong><br><strong>projects that combine medical progress with economic potential. <\/strong><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/healthcare-icon.png\" alt=\"Icon Healthcare-Investments bei Invesdor\" class=\"wp-image-18884\" style=\"width:187px;height:auto\" srcset=\"https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/healthcare-icon.png 300w, https:\/\/www.invesdor.com\/blog\/wp-content\/uploads\/2026\/03\/healthcare-icon-150x150.png 150w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\"\/><\/figure>\n<\/div>\n\n\n<p class=\"has-text-align-center\"><strong>Start today and invest in a healthier future!<\/strong>&#xA0;<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background has-text-align-center wp-element-button\" href=\"https:\/\/www.invesdor.com\/rounds#\/\" style=\"background-color:#a2006e\" target=\"_blank\" rel=\"noreferrer noopener\">View MedTech\/Health Care Investment Projects<\/a><\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From diagnosis to therapy: how investments are transforming the medical and healthcare industry and strengthening portfolios How do&#xA0;investments&#xA0;in&#xA0;healthcare&#xA0;help&#xA0;close&#xA0;gaps&#xA0;in care&#xA0;while&#xA0;also&#xA0;generating&#xA0;returns?&#xA0; MedTech and&#xA0;healthcare&#xA0;investments&#xA0;are&#xA0;among&#xA0;the&#xA0;most&#xA0;stable&#xA0;and at&#xA0;the&#xA0;same time&#xA0;most&#xA0;innovative&#xA0;segments&#xA0;of&#xA0;the&#xA0;global&#xA0;healthcare&#xA0;market.&#xA0;&#xA0;&#xA0; MedTech and healthcare investments refer to capital allocated to companies that develop and commercialize medical technologies, digital health solutions, or healthcare infrastructure. While&#xA0;many&#xA0;markets&#xA0;are&#xA0;subject&#xA0;to&#xA0;strong&#xA0;fluctuations,&#xA0;the&#xA0;demand&#xA0;for&#xA0;medical&#xA0;and&#xA0;healthcare&#xA0;services&#xA0;remains&#xA0;constant.&#xA0;It&#xA0;continues&#xA0;to&#xA0;grow&#xA0;with&#xA0;an&#xA0;aging&#xA0;population,&#xA0;increasing&#xA0;life&#xA0;expectancy&#xA0;&#xA0;(according&#xA0;to&#xA0;the&#xA0;Deloitte Global Health Care Outlook &#x2026;<\/p>\n","protected":false},"author":50,"featured_media":19414,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[121,89,91],"tags":[],"class_list":["post-18901","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-knowledge","category-market-companies"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/posts\/18901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/users\/50"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/comments?post=18901"}],"version-history":[{"count":227,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/posts\/18901\/revisions"}],"predecessor-version":[{"id":19759,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/posts\/18901\/revisions\/19759"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/media\/19414"}],"wp:attachment":[{"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/media?parent=18901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/categories?post=18901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invesdor.com\/blog\/wp-json\/wp\/v2\/tags?post=18901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}